Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmad Hamad

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
American Journal of Surgery|November 28, 2017
Resident attitudes and compliance towards robotic surgical trainingVernissia Tam, Waseem Lutfi, Stephanie Novak, et al.
Surgery|May 20, 2022
In search of lost time: Delays in adjuvant therapy for pancreatic adenocarcinoma among under-resourced patient populationsAhmad Hamad, Mariam F Eskander, Chengli Shen, et al.
Annals of Surgery|October 31, 2019
Oncologic Outcomes After Robotic Pancreatic Resections Are Not Inferior to Open SurgeryMark D Girgis, Mazen S Zenati, Jonathan C King, et al.
Annals of Surgical Oncology|May 16, 2018
FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel for Neoadjuvant Treatment of Resectable and Borderline Resectable Pancreatic Head AdenocarcinomaMashaal Dhir, Mazen S Zenati, Ahmad Hamad, et al.
Surgical Oncology|February 22, 2023
Colonoscopy, imaging, and carcinoembryonic antigen: Comparison of guideline adherence to surveillance strategies in patients who underwent resection of colorectal cancer - A systematic review and meta-analysisZaiba Shafik Dawood, Ahmad Hamad, Zorays Moazzam, et al.
Surgery|February 4, 2022
Surgical treatment of hepatic oligometastatic pancreatic ductal adenocarcinoma: An analysis of the National Cancer DatabaseAhmad Hamad, Jennifer Underhill, Aliya Ansari, et al.
Annals of Surgical Oncology|May 23, 2018
CA19-9 on Postoperative Surveillance in Pancreatic Ductal Adenocarcinoma: Predicting Recurrence and Changing Prognosis over TimeCaroline J Rieser, Mazen Zenati, Ahmad Hamad, et al.
Annals of Surgical Oncology|January 4, 2020
Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic AdenocarcinomaAmr I Al Abbas, Mazen Zenati, Caroline J Reiser, et al.
Annals of Surgical Oncology|July 7, 2017
Analysis of Perioperative Chemotherapy in Resected Pancreatic Cancer: Identifying the Number and Sequence of Chemotherapy Cycles Needed to Optimize SurvivalIrene Epelboym, Mazen S Zenati, Ahmad Hamad, et al.
Annals of Surgical Oncology|February 9, 2020
Correction to: Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic AdenocarcinomaAmr I Al Abbas, Mazen Zenati, Caroline J Rieser, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
American Journal of Surgery|November 28, 2017
Resident attitudes and compliance towards robotic surgical trainingVernissia Tam, Waseem Lutfi, Stephanie Novak, et al.
Surgery|May 20, 2022
In search of lost time: Delays in adjuvant therapy for pancreatic adenocarcinoma among under-resourced patient populationsAhmad Hamad, Mariam F Eskander, Chengli Shen, et al.
Annals of Surgery|October 31, 2019
Oncologic Outcomes After Robotic Pancreatic Resections Are Not Inferior to Open SurgeryMark D Girgis, Mazen S Zenati, Jonathan C King, et al.
Annals of Surgical Oncology|May 16, 2018
FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel for Neoadjuvant Treatment of Resectable and Borderline Resectable Pancreatic Head AdenocarcinomaMashaal Dhir, Mazen S Zenati, Ahmad Hamad, et al.
Surgical Oncology|February 22, 2023
Colonoscopy, imaging, and carcinoembryonic antigen: Comparison of guideline adherence to surveillance strategies in patients who underwent resection of colorectal cancer - A systematic review and meta-analysisZaiba Shafik Dawood, Ahmad Hamad, Zorays Moazzam, et al.
Surgery|February 4, 2022
Surgical treatment of hepatic oligometastatic pancreatic ductal adenocarcinoma: An analysis of the National Cancer DatabaseAhmad Hamad, Jennifer Underhill, Aliya Ansari, et al.
Annals of Surgical Oncology|May 23, 2018
CA19-9 on Postoperative Surveillance in Pancreatic Ductal Adenocarcinoma: Predicting Recurrence and Changing Prognosis over TimeCaroline J Rieser, Mazen Zenati, Ahmad Hamad, et al.
Annals of Surgical Oncology|January 4, 2020
Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic AdenocarcinomaAmr I Al Abbas, Mazen Zenati, Caroline J Reiser, et al.
Annals of Surgical Oncology|July 7, 2017
Analysis of Perioperative Chemotherapy in Resected Pancreatic Cancer: Identifying the Number and Sequence of Chemotherapy Cycles Needed to Optimize SurvivalIrene Epelboym, Mazen S Zenati, Ahmad Hamad, et al.
Annals of Surgical Oncology|February 9, 2020
Correction to: Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic AdenocarcinomaAmr I Al Abbas, Mazen Zenati, Caroline J Rieser, et al.
Pageof 8